CRIS logo

Curis, Inc.

CRIS
Healthcare|Biotechnology|US
$0.91
+0.06 (+6.65%)
Cash / Share
$2.63
Next Earnings Report
Nov 12, 2026
EPS est. -$2.01 · Revenue est. $1.0M
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Aug 13, 2026 (424B4). Possible dilution.

Upcoming Data Readouts (4)

Jul 2027
Est. completion
P1P2Relapsed Hematologic Malignancy
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
NCT03328078n=152
Nov 2027
Est. completion
P2Chronic Lymphocytic Leukemia
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies
NCT07271667n=108
Jul 2028
Est. completion
P1Gastric Cancer
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
NCT05187182n=42
Jun 2030
Est. completion
P1Metastatic Biliary Tract Cancer
Emavusertib (CA-4948) in Combination With Cisplatin, Gemcitabine, and Durvalumab in Patients With Untreated Advanced or Metastatic Biliary Tract Cancer
NCT07107750n=48

Recent Press Releases

Curis to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on November 12, 2026
Nov 5, 2026 · PRNewsWire
Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors
Oct 16, 2026 · PRNewsWire
Curis, Inc. Announces Pricing of $5.6 Million Public Offering
Aug 13, 2026 · PRNewsWire

SEC Filings (81)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Nov 6, 20268-KMaterial eventDocumentIndex
Nov 2, 2026DEF 14AProxy / shareholder voteDocumentIndex
Oct 23, 2026PRE 14AProxy / shareholder voteDocumentIndex
Oct 19, 20268-KMaterial eventDocumentIndex
Aug 13, 2026424B4Offering prospectusDocumentIndex
Aug 12, 2026EFFECTDocumentIndex
Aug 10, 2026S-1IPO / offering registrationDocumentIndex
Jul 30, 20268-KMaterial eventDocumentIndex
Jul 2, 20268-KMaterial eventDocumentIndex
Jul 1, 20268-K/AMaterial eventDocumentIndex
Jul 1, 20268-KMaterial eventDocumentIndex
Jun 25, 20268-KMaterial eventDocumentIndex
Jun 5, 2026DEF 14AProxy / shareholder voteDocumentIndex
May 22, 2026PRE 14AProxy / shareholder voteDocumentIndex
May 22, 20268-KMaterial eventDocumentIndex
May 15, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
May 13, 202610-QQuarterly reportDocumentIndex
May 12, 20268-KMaterial eventDocumentIndex
May 1, 20268-KMaterial eventDocumentIndex
Apr 24, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 21, 2026ARSAnnual report to holdersDocumentIndex
Apr 21, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 10, 2026PRE 14AProxy / shareholder voteDocumentIndex
Apr 7, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Apr 7, 2026SC 13GPassive 5%+ stakeDocumentIndex
Mar 27, 2026SC 13GPassive 5%+ stakeDocumentIndex
Mar 24, 202610-KAnnual reportDocumentIndex
Mar 20, 2026EFFECTDocumentIndex
Mar 19, 20268-KMaterial eventDocumentIndex
Mar 17, 20268-KMaterial eventDocumentIndex
Feb 19, 2026DEF 14AProxy / shareholder voteDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 13, 2026S-3Shelf registrationDocumentIndex
Feb 9, 2026PRE 14AProxy / shareholder voteDocumentIndex
Feb 9, 20268-KMaterial eventDocumentIndex
Jan 23, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jan 8, 20268-KMaterial eventDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 13, 20258-K/AMaterial eventDocumentIndex